WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009850) HCV REPLICATION SYSTEM AND METHODS OF USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009850    International Application No.:    PCT/US2003/022590
Publication Date: 29.01.2004 International Filing Date: 18.07.2003
IPC:
C07K 14/18 (2006.01), G01N 33/50 (2006.01), G01N 33/576 (2006.01)
Applicants: MICROLOGIX BIOTECH INC. [CA/CA]; 3650 Wesbrook Mall, Vancouver, British Columbia V6S 2L2 (CA) (For All Designated States Except US).
LAAKEL, Mohamed [CA/CA]; (CA) (For US Only).
PEPE, Jeffrey, C. [US/US]; (US) (SD only)
Inventors: LAAKEL, Mohamed; (CA)
Agent: PEPE, Jeffrey, C.; Seed Intellectual Property Law Group PLLC, Suite 6300, 701 Fifth Avenue, Seattle, WA 98104-7092 (US)
Priority Data:
60/396,775 18.07.2002 US
Title (EN) HCV REPLICATION SYSTEM AND METHODS OF USE THEREOF
(FR) SYSTEME DE REPLICATION DU VIRUS DE L'HEPATITE C ET PROCEDES D'UTILISATION
Abstract: front page image
(EN)The present invention relates generally to methods of replicating hepatitis C virus (HCV) and, more specifically, to cultured human cells lines that can be infected with, and support the expression of, HCV genetic materials and production of HCV particles over many generations. The invention further relates to the use of such a cell culture system to identify agents useful in the prevention or treatment of HCV infections.
(FR)La présente invention concerne des procédés de réplication du virus de l'hépatite C (HCV), notamment des lignées cellulaires humaines pouvant être infectées par ledit virus, supportant l'expression du virus de l'hépatite C, des matériaux génétiques du virus de l'hépatite C, et la production de particules du virus de l'hépatite C sur plusieurs générations. L'invention concerne également l'utilisation d'un tel système de culture cellulaire afin d'identifier des agents servant à la prévention ou au traitement d'infections par le virus de l'hépatite C.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)